Blog
75 Articles
![Dr. Eugene Koay](https://letswinpc.org/wp-content/uploads/2022/02/Eugene-Koay-horiz.jpg)
Platform Trial Design Aims to Get Information Quickly and Efficiently
Dr. Eugene Koay is leading a platform trial, for a more nimble way to adapt to participants’ response to treatments being tested.
![blood being drawn for a test](https://letswinpc.org/wp-content/uploads/2022/10/Blood-test.jpg)
Liquid Biopsies: What You Should Know
Three different liquid biopsy blood tests are under development or now available for pancreatic and other cancers.
![Let's Win pancreatic cancer logo](https://letswinpc.org/wp-content/uploads/2019/06/LW-logo.jpg)
A Report from ASCO GI 2022
Clinical trials were reported on at ASCO GI 2022, as well as reports on COVID, virtual tumor boards, and racial disparities in treatment.
![pancreatic cancer patients Davi D'Agostino and Steven Merlin](https://letswinpc.org/wp-content/uploads/2022/09/mpc2022jan4.jpg)
Steven Merlin and Davi D’Agostino Team Up to Help Others
Pancreatic cancer patient advocates Steven Merlin and Davi D’Agostino have joined to pool expertise and information for other patients.
![microscope on a blue background](https://letswinpc.org/wp-content/uploads/2022/10/microscope-on-blue-background-1.jpg)
Pancreatic Cancer Science—2021 in Review
As the year winds down Let’s Win provides an overall look at the highlights of 2021 in pancreatic cancer science.
![Anup Kasi](https://letswinpc.org/wp-content/uploads/2021/12/Anup-Kasi-v2.jpg)
Learn More About Qualifying for Clinical Trials
Dr. Anup Kasi provides in-depth information and answers questions about qualifying for pancreatic cancer clinical trials.
![Pancreatic Cancer Action Network](https://letswinpc.org/wp-content/uploads/2021/11/partners-nov2022-pancreatic-cancer-action-network2.gif)
PanCAN 2021 Annual Scientific Summit
Pancreatic Cancer Action Network (PanCAN) held its annual scientific summit for an overview of the latest research projects they are funding.
![Dr. Elizabeth Jaffee](https://letswinpc.org/wp-content/uploads/2022/10/Elizabeth-Jaffee.jpg)
New Clinical Accelerator Initiative Shortens Time from Bench to Clinic
Dr. Elizabeth Jaffee explains the importance of Lustgarten’s Clinical Accelerator Initiative to speed up the time from bench to trial.
![clinical trials webinar announcement](https://letswinpc.org/wp-content/uploads/2021/10/webinar-graphic-28Oct2021.jpg)
The Importance of Clinical Trials Webinar
The fourth Let’s Learn webinar features a discussion between patients and doctors about the value of clinical trials.
![clinical trials webinar announcement](https://letswinpc.org/wp-content/uploads/2021/10/webinar-graphic-28Oct2021.jpg)
Let’s Learn Webinar on Clinical Trials on October 28th
Join Let’s Win for a webinar on the Importance of Clinical Trials, to learn more about participating in a trial as part of treatment.
![Let's Win, Lustgarten Foundation, and AACR logos](https://letswinpc.org/wp-content/uploads/2022/10/LW-LF-AACR.gif)
The American Association for Cancer Research (AACR) Virtual Special Conference: Pancreatic Cancer Day One
Let’s Win and the Lustgarten Foundation present highlights of Day One of the AACR Virtual Special Conference on Pancreatic Cancer.
![Cancer Commons nurse navigator Deborah Christensen](https://letswinpc.org/wp-content/uploads/2022/08/mpc2021aug24.jpg)
Cancer Commons: Bringing a Nurse Navigator to Cancer Patients
Nurse navigator Deborah Christensen helps Cancer Commons patients through the maze of clinical trials and treatment options.
![Drs. Kelly Herremans and Jose Trevino](https://letswinpc.org/wp-content/uploads/2022/10/Herremans-Trevino.jpg)
Diversity Lacking in Pancreatic Cancer Trials
Drs. Kelly Herremans and Jose Trevino report on the lack of diversity in pancreatic cancer clinical trials, and possible root causes.
![green pills](https://letswinpc.org/wp-content/uploads/2022/10/green-pills.jpg)
Reducing Pancreatic Cancer Risk Through Chemoprevention
Dr. Peter Allen leads a clinical trial of chemoprevention–the use of a medication to prevent IPMNs from developing into pancreatic cancer.